BACE1-/- mice exhibit seizure activity that does not correlate with sodium channel level or axonal localization

Molecular Neurodegeneration

Volumn 5, Issue 1, 2010, Pages

  Hitt, Brian D ^a   Jaramillo, Thomas C ^a   Chetkovich, Dane M ^a   Vassar, Robert ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA SECRETASE 1; KAINIC ACID; SODIUM CHANNEL NAV1.2;

ABSENCE SEIZURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE SEVERITY; EEG ABNORMALITY; ELECTROENCEPHALOGRAPHY; EPILEPTIC DISCHARGE; EXCITOTOXICITY; GENOTYPE; GRAND MAL EPILEPSY; MOSSY FIBER; MOUSE; NERVE DEGENERATION; NERVE FIBER; NONHUMAN; PHENOTYPE; SEIZURE; SEIZURE SUSCEPTIBILITY;

MUS;

EID: 77955792343     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-5-31     Document Type: Article

References (58)

1. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. GG Glenner CW Wong, Biochem Biophys Res Commun 1984 122 1131 1135 10.1016/0006-291X(84)91209-9 6236805
2. Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. CL Masters G Multhaup G Simms J Pottigiesser RN Martins K Beyreuther, EMBO Journal 1985 4 2757 2763 4065091
3. gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? SS Sisodia PH St George-Hyslop, Nat Rev Neurosci 2002 3 281 290 10.1038/nrn785 11967558
4. Biochemistry and Molecular Biology of Amyloid beta-Protein and the Mechanism of Alzheimer's Disease. DJ Selkoe, Handb Clin Neurol 2008 89 245 260 full-text 18631749
5. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. RE Tanzi L Bertram, Cell 2005 120 545 555 10.1016/j.cell.2005.02. 008 15734686
6. Identification of a novel aspartic protease (Asp 2) as beta-secretase. I Hussain D Powell DR Howlett DG Tew TD Meek C Chapman IS Gloger KE Murphy CD Southan DM Ryan TS Smith DL Simmons FS Walsh C Dingwall G Christie, Molecular and Cellular Neuroscience 1999 14 419 427 10.1006/mcne.1999.0811 10656250
7. Purification and cloning of amyloid precursor protein beta-secretase from human brain. S Sinha JP Anderson R Barbour GS Basi R Caccavello D Davis M Doan HF Dovey N Frigon J Hong K Jacobson-Croak N Jewett P Keim J Knops I Lieberburg M Power H Tan G Tatsuno J Tung D Schenk P Seubert SM Suomensaari S Wang D Walker J Zhao L McConlogue V John, Nature 1999 402 537 540 10.1038/990114 10591214
8. Beta-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. R Vassar BD Bennett S Babu-Khan S Kahn EA Mendiaz P Denis DB Teplow S Ross P Amarante R Loeloff Y Luo S Fisher J Fuller S Edenson J Lile MA Jarosinski AL Biere E Curran T Burgess JC Louis F Collins J Treanor G Rogers M Citron, Science 1999 286 735 741 10.1126/science.286.5440.735 10531052
9. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. R Yan MJ Bienkowski ME Shuck H Miao MC Tory AM Pauley JR Brashler NC Stratman WR Mathews AE Buhl DB Carter AG Tomasselli LA Parodi RL Heinrikson ME Gurney, Nature 1999 402 533 537 10.1038/990107 10591213
10. Human aspartic protease memapsin 2 cleaves the -secretase site of -amyloid precursor protein. X Lin G Koelsch S Wu D Downs A Dashti J Tang, Proc Natl Acad Sci USA 2000 97 1456 1460 10.1073/pnas.97.4.1456 10677483
11. Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Y Luo B Bolon S Kahn BD Bennett S Babu-Khan P Denis W Fan H Kha J Zhang Y Gong L Martin JC Louis Q Yan WG Richards M Citron R Vassar, Nature Neurosci 2001 4 231 232 10.1038/85059 11224535
12. BACE1 Deficiency Rescues Memory Deficits and Cholinergic Dysfunction in a Mouse Model of Alzheimer's Disease. M Ohno EA Sametsky LH Younkin H Oakley SG Younkin M Citron R Vassar JF Disterhoft, Neuron 2004 41 27 33 10.1016/S0896-6273(03)00810-9 14715132
13. BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. FM Laird H Cai AV Savonenko MH Farah K He T Melnikova H Wen HC Chiang G Xu VE Koliatsos DR Borchelt DL Price HK Lee PC Wong, J Neurosci 2005 25 11693 11709 10.1523/JNEUROSCI.2766-05.2005 16354928
14. BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice. M Ohno SL Cole M Yasvoina J Zhao M Citron R Berry JF Disterhoft R Vassar, Neurobiology of disease 2007 26 134 145 10.1016/j.nbd.2006.12.008 17258906
15. Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP Transgenic Mice. L McConlogue M Buttini JP Anderson EF Brigham KS Chen SB Freedman D Games K Johnson-Wood M Lee M Zeller W Liu R Motter S Sinha, The Journal of biological chemistry 2007 282 26326 26334 10.1074/jbc.M611687200 17616527
16. Alzheimer's beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase. S Kitazume Y Tachida R Oka K Shirotani TC Saido Y Hashimoto, Proc Natl Acad Sci USA 2001 98 13554 13559 10.1073/pnas.241509198 11698669
17. The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1. SF Lichtenthaler DI Dominguez GG Westmeyer K Reiss C Haass P Saftig B De Strooper B Seed, The Journal of biological chemistry 2003 278 48713 48719 10.1074/jbc.M303861200 14507929
18. The proteolytic processing of the amyloid precursor protein gene family members APLP-1 and APLP-2 involves alpha-, beta-, gamma-, and epsilon-like cleavages: modulation of APLP-1 processing by n-glycosylation. S Eggert K Paliga P Soba G Evin CL Masters A Weidemann K Beyreuther, The Journal of biological chemistry 2004 279 18146 18156 10.1074/jbc.M311601200 14970212
19. Cleavage of amyloid-beta precursor protein and amyloid-beta precursor-like protein by BACE 1. Q Li TC Sudhof, The Journal of biological chemistry 2004 279 10542 10550 10.1074/jbc.M310001200 14699153
20. BACE (beta-secretase) modulates the processing of APLP2 in vivo. L Pastorino AF Ikin S Lamprianou N Vacaresse JP Revelli K Platt P Paganetti PM Mathews S Harroch JD Buxbaum, Mol Cell Neurosci 2004 25 642 649 10.1016/j.mcn.2003.12.013 15080893
21. The low density lipoprotein receptor-related protein (LRP) is a novel beta-secretase (BACE1) substrate. CA von Arnim A Kinoshita ID Peltan MM Tangredi L Herl BM Lee R Spoelgen TT Hshieh S Ranganathan FD Battey CX Liu BJ Bacskai S Sever MC Irizarry DK Strickland BT Hyman, The Journal of biological chemistry 2005 280 17777 17785 10.1074/jbc.M414248200 15749709
22. Presenilin/gamma-secretase-mediated cleavage of the voltage-gated sodium channel beta2-subunit regulates cell adhesion and migration. DY Kim LA Ingano BW Carey WH Pettingell DM Kovacs, The Journal of biological chemistry 2005 280 23251 23261 10.1074/jbc.M412938200 15833746
23. beta Subunits of voltage-gated sodium channels are novel substrates of beta-site amyloid precursor protein-cleaving enzyme (BACE1) and gamma-secretase. HK Wong T Sakurai F Oyama K Kaneko K Wada H Miyazaki M Kurosawa B De Strooper P Saftig N Nukina, The Journal of biological chemistry 2005 280 23009 23017 10.1074/jbc.M414648200 15824102
24. Bace1 modulates myelination in the central and peripheral nervous system. X Hu CW Hicks W He P Wong WB Macklin BD Trapp R Yan, Nature neuroscience 2006 9 1520 1525 10.1038/nn1797 17099708
25. Control of peripheral nerve myelination by the beta-secretase BACE1. M Willem AN Garratt B Novak M Citron S Kaufmann A Rittger B DeStrooper P Saftig C Birchmeier C Haass, Science 2006 314 664 666 10.1126/science.1132341 16990514
26. Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves. X Hu W He C Diaconu X Tang GJ Kidd WB Macklin BD Trapp R Yan, Faseb J 2008 22 2970 2980 10.1096/fj.08-106666 18413858
27. BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. H Cai Y Wang D McCarthy H Wen DR Borchelt DL Price PC Wong, Nature Neurosci 2001 4 233 234 10.1038/85064 11224536
28. BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. SL Roberds J Anderson G Basi MJ Bienkowski DG Branstetter KS Chen SB Freedman NL Frigon D Games K Hu, et al. Hum Mol Genet 2001 10 1317 1324 10.1093/hmg/10.12. 1317 11406613
29. Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice. D Dominguez J Tournoy D Hartmann T Huth K Cryns S Deforce L Serneels IE Camacho E Marjaux K Craessaerts AJ Roebroek M Schwake R D'Hooge P Bach U Kalinke D Moechars C Alzheimer K Reiss P Saftig B De Strooper, The Journal of biological chemistry 2005 280 30797 30806 10.1074/jbc.M505249200 15987683
30. Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice. AV Savonenko T Melnikova FM Laird KA Stewart DL Price PC Wong, Proc Natl Acad Sci USA 2008 105 5585 5590 10.1073/pnas.0710373105 18385378
31. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. WA Catterall, Neuron 2000 26 13 25 10.1016/S0896-6273(00)81133-2 10798388
32. Sodium channel beta4, a new disulfide-linked auxiliary subunit with similarity to beta2. FH Yu RE Westenbroek I Silos-Santiago KA McCormick D Lawson P Ge H Ferriera J Lilly PS DiStefano WA Catterall T Scheuer R Curtis, J Neurosci 2003 23 7577 7585 12930796
33. Sodium channel beta subunits: anything but auxiliary. LL Isom, Neuroscientist 2001 7 42 54 10.1177/107385840100700108 11486343
34. The distribution and targeting of neuronal voltage-gated ion channels. HC Lai LY Jan, Nat Rev Neurosci 2006 7 548 562 10.1038/nrn1938 16791144
35. BACE1 regulates voltage-gated sodium channels and neuronal activity. DY Kim BW Carey H Wang LA Ingano AM Binshtok MH Wertz WH Pettingell P He VM Lee CJ Woolf DM Kovacs, Nat Cell Biol 2007 9 755 764 10.1038/ncb1602 17576410
36. Non-proteolytic effect of beta-site APP-cleaving enzyme 1 (BACE1) on sodium channel function. T Huth K Schmidt-Neuenfeldt A Rittger P Saftig K Reiss C Alzheimer, Neurobiology of disease 2009 33 282 289 10.1016/j.nbd.2008.10.015 19056495
37. BACE1 as a potential mediator of stress response in the brain. B Hitt T O'Connor E Maus RJ Vassar, Washington, DC: Society for Neuroscience 2008 Program No. 438.9. 2008 Neuroscience Meeting Planner, Online
38. Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. RH Wallace DW Wang R Singh IE Scheffer AL George HA Phillips K Saar A Reis EW Johnson GR Sutherland SF Berkovic JC Mulley, Nat Genet 1998 19 366 370 10.1038/448 9697698
39. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. L Claes J Del-Favero B Ceulemans L Lagae C Van Broeckhoven P De Jonghe, Am J Hum Genet 2001 68 1327 1332 10.1086/320609 11359211
40. A deletion in SCN1B is associated with febrile seizures and early-onset absence epilepsy. D Audenaert L Claes B Ceulemans A Lofgren C Van Broeckhoven P De Jonghe, Neurology 2003 61 854 856 14504340
41. Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutations. IE Scheffer LA Harkin BE Grinton LM Dibbens SJ Turner MA Zielinski R Xu G Jackson J Adams M Connellan S Petrou RM Wellard RS Briellmann RH Wallace JC Mulley SF Berkovic, Brain 2007 130 100 109 10.1093/brain/awl272 17020904
42. Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy. KD Holland JA Kearney TA Glauser G Buck M Keddache JR Blankston IW Glaaser RS Kass MH Meisler, Neurosci Lett 2008 433 65 70 10.1016/j.neulet.2007.12.064 18242854
43. Impaired NaV1.2 function and reduced cell surface expression in benign familial neonatal-infantile seizures. SN Misra KM Kahlig AL George, Epilepsia 2008 49 1535 1545 10.1111/j.1528-1167.2008.01619.x 18479388
44. Sodium channel mutations in epilepsy and other neurological disorders. MH Meisler JA Kearney, J Clin Invest 2005 115 2010 2017 10.1172/JCI25466 16075041
45. Single gene defects in mice: the role of voltage-dependent calcium channels in absence models. DL Burgess JL Noebels, Epilepsy Res 1999 36 111 122 10.1016/S0920-1211(99)00045-5 10515159
46. Absence epilepsy in apathetic, a spontaneous mutant mouse lacking the h channel subunit, HCN2. WK Chung M Shin TC Jaramillo RL Leibel CA LeDuc SG Fischer E Tzilianos AA Gheith AS Lewis DM Chetkovich, Neurobiol Dis 2009 33 499 508 10.1016/j.nbd.2008.12.004 19150498
47. Ethosuximide (Zarontin) and other succinimides. TR Browne, Epilepsy: Diagnosis and Management Boston, Mass: Little Brown & Co, Browne TR, Feldman RG, 1983 215 224
48. Anticonvulsant sensitivity of absence seizures in the tottering mutant mouse. AH Heller MA Dichter RL Sidman, Epilepsia 1983 24 25 34 10.1111/j.1528-1157.1983.tb04862.x 6401628
49. Epileptiform activity and neural plasticity in limbic structures. RJ Racine JG Gartner WM Burnham, Brain Res 1972 47 262 268 10.1016/0006-8993(72) 90268-5 4641271
50. Neuronal stress and injury in C57/BL mice after systemic kainic acid administration. RQ Hu S Koh T Torgerson AJ Cole, Brain Res 1998 810 229 240 10.1016/S0006-8993(98)00863-4 9813346
51. Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis. J Zhao Y Fu M Yasvoina P Shao B Hitt T O'Connor S Logan E Maus M Citron R Berry L Binder R Vassar, J Neurosci 2007 27 3639 3649 10.1523/JNEUROSCI.4396-06.2007 17409228
52. BACE1 deficiency causes altered neuronal activity and neurodegeneration. X Hu X Zhou W He J Yang W Xiong P Wong CG Wilson R Yan, J Neurosci 2010 30 8819 8829 10.1523/JNEUROSCI.1334-10.2010 20592204
53. Thalamic synchrony and dynamic regulation of global forebrain oscillations. JR Huguenard DA McCormick, Trends Neurosci 2007 30 350 356 10.1016/j.tins.2007.05.007 17544519
54. Spatial and temporal control of age-related APP processing in genomic-based beta-secretase transgenic mice. MJ Chiocco BT Lamb, Neurobiol Aging 2007 28 75 84 10.1016/j.neurobiolaging.2005.11.011 16387391
55. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. JR Cirrito KA Yamada MB Finn RS Sloviter KR Bales PC May DD Schoepp SM Paul S Mennerick DM Holtzman, Neuron 2005 48 913 922 10.1016/j.neuron.2005.10. 028 16364896
56. APP processing and synaptic function. F Kamenetz T Tomita H Hsieh G Seabrook D Borchelt T Iwatsubo S Sisodia R Malinow, Neuron 2003 37 925 937 10.1016/S0896-6273(03)00124-7 12670422
57. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. H Hsieh J Boehm C Sato T Iwatsubo T Tomita S Sisodia R Malinow, Neuron 2006 52 831 843 10.1016/j.neuron.2006.10.035 17145504
58. Absence seizures in succinic semialdehyde dehydrogenase deficient mice: a model of juvenile absence epilepsy. MA Cortez Y Wu KM Gibson OC Snead, Pharmacol Biochem Behav 2004 79 547 553 10.1016/j.pbb.2004.09.008 15582027